JP7427734B1 - Medication guidance system, medication guidance method, and medication guidance program - Google Patents

Abstract

[Problem] To facilitate the selection of materials to be presented to a patient for use in medication guidance. In a medication guidance system 100, characteristics of each of a plurality of materials to be presented to a patient are stored as material characteristic information. When giving medication guidance, the medication guidance system 100 refers to material characteristic information to identify one or more materials having characteristics that correspond to a patient to whom a medicine is prescribed. The medication guidance system 100 presents each of the one or more identified materials based on priority. [Selection diagram] Figure 1

Description

The present disclosure relates to technology for supporting medication guidance.

Pharmacists not only perform physical duties such as dispensing medicines according to prescriptions, but also perform interpersonal duties such as instructing patients to take medication. Differences in the experience or knowledge of pharmacists tend to manifest as differences in the quality of medication guidance. It is desired to be able to provide high-quality medication guidance regardless of the pharmacist in charge.

Patent Document 1 describes extracting and displaying side effects that are highly necessary to be explained to patients. This aims to reduce the burden on pharmacists when selecting which side effects should be explained from among a wide variety of side effects.

JP2022-052905A

When providing medication guidance, we not only provide guidance on items that must be taught, such as explanations of side effects, but also various explanations such as how to take medications and useful advice for promoting the patient's health. Depending on the content of the explanation, it may be difficult for patients to understand using words alone. Pharmaceutical manufacturers provide pharmacies with materials that can be presented to patients in order to support pharmacists' explanations to patients. However, there are many materials available, and it is difficult to select the appropriate material for the patient. As a result, the utilization of materials is not progressing.

Patent Document 1 describes that side effects that need to be explained to patients are extracted. However, Patent Document 1 does not describe how to extract appropriate materials suitable for a patient.

The present disclosure aims to facilitate the selection of materials for use in medication guidance.

The medication guidance system according to the present disclosure is
A material identification unit that identifies one or more materials having characteristics corresponding to a patient to whom a drug is prescribed by referring to a material characteristic storage unit that stores characteristics of each of a plurality of materials to be presented to a patient during medication guidance; and,
and a presentation unit that presents each of the one or more materials specified by the material identification unit based on priority.

In this disclosure, one or more materials with patient-compatible properties are identified and presented. This allows pharmacists to easily select appropriate materials.

1 is a configuration diagram of a medication guidance system 100 according to Embodiment 1. FIG. 1 is a configuration diagram of a medication guidance device 10 according to Embodiment 1. FIG. FIG. 2 is a configuration diagram of a pharmacy terminal 20 according to the first embodiment. FIG. 3 is an explanatory diagram of patient information 131 according to the first embodiment. FIG. 3 is an explanatory diagram of prescription information 132 according to the first embodiment. FIG. 3 is an explanatory diagram of material characteristic information 133 according to the first embodiment. FIG. 2 is an explanatory diagram of material information 231 according to the first embodiment. 1 is a flowchart of overall processing of the medication guidance system 100 according to the first embodiment. 5 is a flowchart of instruction information transmission processing according to the first embodiment. 5 is a flowchart of instruction information display processing according to the first embodiment. FIG. 3 is an explanatory diagram of displayed information according to the first embodiment. 5 is a flowchart of instruction result registration processing according to the first embodiment. FIG. 7 is an explanatory diagram of material characteristic information 133 according to Modification 3. FIG. 7 is an explanatory diagram of material characteristic information 133 according to the second embodiment. 7 is a flowchart of instruction information transmission processing according to Embodiment 2. 7 is a flowchart of instruction information display processing according to Embodiment 2. 7 is a flowchart of instruction result registration processing according to Embodiment 2.

Embodiment 1.
***Explanation of configuration***
The configuration of a medication guidance system 100 according to Embodiment 1 will be described with reference to FIG. 1.
The medication guidance system 100 includes a medication guidance device 10 and one or more pharmacy terminals 20. The medication guidance device 10 and each pharmacy terminal 20 are connected via a network 90.
The medication guidance device 10 is a computer such as a cloud server. The pharmacy terminal 20 is a computer such as a PC installed in the pharmacy 30 and operated by a pharmacist. PC is an abbreviation for Personal Computer.
A plurality of pharmacy terminals 20 may be installed in the same pharmacy 30. Furthermore, when a plurality of pharmacy terminals 20 are installed, different devices such as a PC and a tablet terminal may be installed in combination.

With reference to FIG. 2, the configuration of the medication guidance device 10 according to the first embodiment will be described.
The medication guidance device 10 is a computer.
The medication guidance device 10 includes hardware such as a processor 11 , a memory 12 , a storage 13 , and a communication interface 14 . The processor 11 is connected to other hardware via signal lines and controls these other hardware.

The medication guidance device 10 includes a material identification section 111 and a score setting section 112 as functional components. The functions of each functional component of the medication guidance device 10 are realized by software.
The storage 13 stores programs that implement the functions of each functional component of the medication guidance device 10. This program is read into the memory 12 by the processor 11 and executed by the processor 11. Thereby, the functions of each functional component of the medication guidance device 10 are realized.

The storage 13 stores patient information 131, prescription information 132, and material characteristic information 133.

With reference to FIG. 3, the configuration of the pharmacy terminal 20 according to the first embodiment will be described.
Pharmacy terminal 20 is a computer.
The pharmacy terminal 20 includes hardware such as a processor 21, a memory 22, a storage 23, and a communication interface 24. The processor 21 is connected to other hardware via signal lines and controls these other hardware. When the pharmacy terminal 20 is a PC, it may be connected to a plurality of monitors as hardware.

The pharmacy terminal 20 includes a prescription processing section 211, a presentation section 212, and a validity acceptance section 213 as functional components. The functions of each functional component of the pharmacy terminal 20 are realized by software.
The storage 23 stores programs that implement the functions of each functional component of the pharmacy terminal 20. This program is read into the memory 22 by the processor 21 and executed by the processor 21. Thereby, the functions of each functional component of the pharmacy terminal 20 are realized.

Material information 231 is stored in the storage 23 .

The processors 11 and 21 are ICs that perform processing. IC is an abbreviation for Integrated Circuit. Specific examples of the processors 11 and 21 include a CPU, a DSP, and a GPU. CPU is an abbreviation for Central Processing Unit. DSP is an abbreviation for Digital Signal Processor. GPU is an abbreviation for Graphics Processing Unit.

Memories 12 and 22 are storage devices that temporarily store data. The memories 12 and 22 are, for example, SRAM and DRAM. SRAM is an abbreviation for Static Random Access Memory. DRAM is an abbreviation for Dynamic Random Access Memory.

The storages 13 and 23 are storage devices that store data. The storages 13 and 23 are, for example, HDDs. HDD is an abbreviation for Hard Disk Drive. Furthermore, the storages 13 and 23 are portable recording media such as SD (registered trademark) memory cards, CompactFlash (registered trademark), NAND flash, flexible disks, optical disks, compact discs, Blu-ray (registered trademark) discs, and DVDs. It's okay. SD is an abbreviation for Secure Digital. DVD is an abbreviation for Digital Versatile Disk.

The communication interfaces 14 and 24 are interfaces for communicating with external devices. The communication interfaces 14 and 24 are, for example, Ethernet (registered trademark), USB, and HDMI (registered trademark) ports. USB is an abbreviation for Universal Serial Bus. HDMI is an abbreviation for High-Definition Multimedia Interface.

In FIG. 2, only one processor 11 was shown. However, there may be a plurality of processors 11, and the plurality of processors 11 may cooperate to execute programs that implement each function. Similarly, in FIG. 3, only one processor 21 was shown. However, there may be a plurality of processors 21, and the plurality of processors 21 may cooperate to execute programs that implement each function.

***Operation explanation***
The operation of the medication guidance system 100 according to the first embodiment will be described with reference to FIGS. 4 to 12.
The operation procedure of the medication guidance system 100 according to the first embodiment corresponds to the medication guidance method according to the first embodiment. Further, a program that realizes the operation of the medication guidance system 100 according to the first embodiment corresponds to the medication guidance program according to the first embodiment.

Patient information 131 according to the first embodiment will be described with reference to FIG. 4.
The patient information 131 includes a patient name, pharmacy ID, patient information, and special notes for each patient ID. ID is an abbreviation for IDentifier.
The patient ID is a patient identifier. Here, the patient ID may be any information that can be uniquely identified using the patient information 131, and may be, for example, an insurer number or a branch number. The patient name is the patient's full name. The pharmacy ID is an identifier of a pharmacy that the patient has used. Patient information is patient's personal information such as gender and age. In the special notes, patient header information and disease are recorded. The patient header information indicates the patient's constitution, medical history, concomitant medications, allergies, and favorite items. The disease is a disease that the patient is suffering from, such as hypertension and diabetes.

Prescription information 132 according to Embodiment 1 will be described with reference to FIG. 5.
The prescription information 132 includes drug name, quantity, and usage for each pharmacy ID, patient ID, dispensing date, and medical institution ID.
The pharmacy ID and patient ID are as described above. The dispensing date is the date on which the dispensing was performed. The medical institution ID is an identifier of the medical institution that issued the prescription. The drug name is the name of the prescribed drug. Quantity is the amount of medicine prescribed. Dosage is the way a prescribed drug is used. Although not shown, the prescription information 132 includes medication guidance history that is history information of past medication guidance.

With reference to FIG. 6, material characteristic information 133 according to the first embodiment will be explained.
The material characteristic information 133 includes a set of one or more conditions and an effect score for each pharmacy ID and material ID. The pharmacy ID is as described above. The material ID is an identifier of a material that can be presented to a patient in order to support the pharmacist's explanation to the patient. The materials are provided to the pharmacy by a pharmaceutical manufacturer or the like, or are created independently by the pharmacy, and may include illustrations, photographs, explanatory text, etc., or a combination thereof. Further, the material may be a video or the like for explaining the use.
The conditions are conditions for determining effective materials. A condition is constituted by a set of one or more characteristics. The characteristics include the prescribed drug, prescription timing, gender, age, patient title information, and disease. The prescription timing indicates at least one of the number of prescriptions and the prescription interval of a prescribed drug, such as initial, continuation, or restart. The effectiveness score indicates the effectiveness of the material for the set of characteristics that make up the condition. Here, it is assumed that the larger the value of the effect score, the higher the effectiveness.

The condition in the first line of FIG. 6 means that the patient is "prescribed drug A for the first time, and is a male diabetic patient." The condition in the second line of FIG. 6 means "continuous prescription of drug B". The first and second lines in FIG. 6 are both conditions for the material IDS001. Therefore, the material IDS001 is effective for at least one of "initial prescription of drug A and a male diabetic patient" and "continued prescription of drug B."
The condition in the third line of FIG. 6 means "resumption prescription of drug C". Restarted prescription means that there was a prescription history in the past, there was no prescription history for a certain period of time, and the prescription was given again. Therefore, the material IDS002 is effective when it is a "resumption prescription for drug C."
The condition in the fourth line of FIG. 6 means that "the prescribed drug is D drug." Therefore, the material IDS003 is effective when "the prescribed drug is D drug".
The condition in the fifth line of FIG. 6 means that the patient is a male between 16 and 75 years old and works late at night. The condition in the 6th line of FIG. 6 means that the patient is a "male between 16 and 75 years old and has high blood pressure." The fifth and sixth lines in FIG. 6 are both conditions for the material IDS0034. Therefore, the material IDS004 is effective for at least one of the following: ``Patients who are male between the ages of 16 and 75 and work late nights'' and ``patients who are male between the ages of 16 and 75 and have high blood pressure.'' It will be.
The condition in the 7th line of FIG. 6 means that the patient is 75 years old or older and has hyperlipidemia. Therefore, the material IDS005 is effective for "patients who are 75 years old or older and have hyperlipidemia."

The material information 231 according to the first embodiment will be explained with reference to FIG. 7.
The material information 231 includes a summary and the material for each material ID.
The material ID is as described above. The summary is a brief description of the material's contents. Materials are the materials themselves.
As shown in FIG. 7, the summary is information representing what kind of instruction can be provided using the materials. When storing the material information 231, the outline may be specified by input from a person who has viewed the entire material, or the outline may be identified by machine learning of the material. good.

With reference to FIG. 8, the overall processing of the medication guidance system 100 according to the first embodiment will be described.
(Step S1: Reception display processing)
The prescription processing unit 211 of the pharmacy terminal 20 displays a prescription reception screen. The pharmacist inputs information on the prescription received from the target patient, who is currently being treated, into the reception screen. The prescription information includes the patient ID and name of the target patient, and information on the prescribed drug.

(Step S2: Request sending process)
The prescription processing unit 211 of the pharmacy terminal 20 transmits request information requesting transmission of patient information to the medication guidance device 10. The request information includes the patient ID of the target patient input in step S1 and information on the prescribed drug.

(Step S3: Guidance information transmission process)
The material identification unit 111 of the medication guidance device 10 receives the request information transmitted in step S2. The material specifying unit 111 extracts information about the patient from the patient information 131 and prescription information 132 based on the request information. Furthermore, the material identification unit 111 extracts the material ID from the material characteristic information 133 based on the request information and the extracted information about the patient. The material identification unit 111 transmits information about the patient and the material ID to the pharmacy terminal 20 that is the source of the request information.

(Step S4: Instruction information display processing)
The presentation unit 212 of the pharmacy terminal 20 displays the information about the patient transmitted in step S3 on the display device. Furthermore, the presentation unit 212 extracts the material indicated by the material ID transmitted in step S3 from the material information 231, and displays it on the display device. The pharmacist refers to the information displayed on the display device and provides medication guidance to the target patient.

(Step S5: Guidance result registration process)
The effectiveness reception unit 213 of the pharmacy terminal 20 transmits the effectiveness of medication guidance using materials to the medication guidance device 10 the next time the patient visits the store. The score setting unit 112 of the medication guidance device 10 updates the effectiveness score of the used material based on the effectiveness.

Referring to FIG. 9, the instruction information transmission process (step S3 in FIG. 8) according to the first embodiment will be described.
(Step S31: Information extraction process)
The material specifying unit 111 extracts information about the patient from the patient information 131 and prescription information 132 based on the request information.
Specifically, the material specifying unit 111 extracts the patient name, pharmacy ID, patient information, and special notes information for the target patient from the patient information 131 based on the patient ID included in the request information. Furthermore, the material specifying unit 111 extracts past prescription information from the patient information 131 based on the patient ID included in the request information.
At this time, the material identifying unit 111 may identify information necessary for medication guidance from the extracted information. The information necessary for medication guidance is, for example, the difference between the previous prescribed medication and the current prescribed medication.

(Step S32: Material ID determination process)
The material specifying unit 111 determines whether there is a material ID that satisfies the conditions based on the request information and the information extracted in step S31.
Specifically, the material specifying unit 111 determines whether there is a material ID that matches the prescribed drug information included in the request information and the information extracted in step S31, which satisfies the conditions in the material characteristic information 133. judge. If there is a material ID that satisfies the conditions, the material specifying unit 111 advances the process to step S33. On the other hand, if there is no material ID that satisfies the conditions, the process advances to step S34.

(Step S33: Material ID extraction process)
The material identification unit 111 extracts material IDs that satisfy the conditions.
Specifically, the material identification unit 111 extracts, from the material characteristic information 133, the material ID of the record determined to satisfy the condition in step S32. At this time, the material specifying unit 111 also extracts the effect score of the record from which the material ID has been extracted.

(Step S34: Information transmission process)
The material specifying unit 111 transmits the information extracted in step S32 to the pharmacy terminal 20 that is the source of the request information. Furthermore, when the combination of material ID and effect score is extracted in step S33, the material identification unit 111 also transmits the combination of material ID and effect score to the pharmacy terminal 20 that is the source of the request information.

Referring to FIG. 10, the instruction information display process (step S4 in FIG. 8) according to the first embodiment will be described.
(Step S41: Information display processing)
As shown in FIG. 11(A), the presentation unit 212 displays the information about the patient transmitted in step S3 on the display device. At this time, the presentation unit 212 may highlight and display information that requires medication guidance. Furthermore, the presentation unit 212 displays the material ID transmitted in step S3 and the summary corresponding to the material ID in the material information 231. At this time, the presentation unit 212 displays materials based on the priority based on the effect score for each material ID transmitted in step S3. For example, the presentation unit 212 displays the material IDs arranged in descending order of effectiveness scores from top to bottom. The presentation unit 212 may display the effect score together with the material ID.

The pharmacist provides medication guidance while checking the information displayed in step S41. When giving medication guidance, the pharmacist provides explanations such as how to take medication and advice useful for promoting the patient's health, depending on the content of the conversation with the patient. Depending on the content of the explanation, it is possible to help the patient's understanding by using materials. When using a material, the pharmacist selects the material ID of the material to be used. At this time, the pharmacist refers to the outline and decides on the materials to be used. Further, when the medication guidance is completed, the pharmacist presses the guidance end button.

(Step S42: Input determination process)
The presentation unit 212 determines whether an input has been made.
If the material ID is selected, the presentation unit 212 advances the process to step S43. When the guidance end button is pressed, the presentation unit 212 transmits medication guidance information for the patient by the pharmacist to the medication guidance device 10, and ends the process. Specifically, the presentation unit 212 transmits the drug name, quantity, and usage to the medication guidance device 10 for each pharmacy ID, patient ID, dispensing date, and medical institution ID as prescription information. In addition, the presentation unit 212 identifies the materials to be used based on the material ID selected by the pharmacist, determines that medication guidance has been provided using the materials, and refers to the material information 213 to include the outline specified from the material ID as well. It is transmitted to the medication guidance device 10 as guidance information. Thereafter, the processing unit (not shown) of the medication guidance device 10 adds data to the prescription information 132 based on the information transmitted by the presentation unit 212. The outline specified from the material ID is stored as a medication guidance history.
If the material ID is not selected and the instruction end button is not pressed, the presentation unit 212 returns the process to step S42.

(Step S43: Material display processing)
As shown in FIG. 11(B), the presentation unit 212 displays the material indicated by the selected material ID on the display device. At this time, the pharmacist may provide medication guidance while showing the patient a screen displaying materials. As described above, if a plurality of monitors are connected to the pharmacy terminal 20, it becomes possible to instruct the patient to take medication while showing materials to the patient by rotating one of the monitors toward the patient. Furthermore, if the pharmacy terminal 20 is a tablet terminal or the like, it becomes possible for the pharmacist and the patient to provide medication guidance while viewing the same screen. Since the material ID selected in step S42 becomes part of the medication guidance information transmitted in step 42, the selected material ID is stored in the memory 22 at the end of step S43.
Furthermore, when displaying materials as shown in FIG. 11(B), a configuration may be adopted in which a plurality of materials are displayed simultaneously. In that case, the materials may be displayed in the order of the material IDs, or since the order of the material IDs is based on the priority, the materials may be displayed with emphasis on ease of viewing based on the priority. Specifically, when displaying four or more materials, for example, there is a method of arranging them at the top left, top right, bottom left, and bottom right, as in the Z law. Also, like F's law, there is a method of arranging them as upper left, lower left, upper right, and lower right.

Referring to FIG. 12, the instruction result registration process (step S5 in FIG. 8) according to the first embodiment will be described.

(Step S51: Validity acceptance process)
The effectiveness level reception unit 213 receives an input of the effectiveness level when medication guidance is given using the material used, which is the material displayed in step S43 when the patient last visited the store. In the first embodiment, the effectiveness indicates whether or not the used materials were effective. For example, it is judged to be effective if medication adherence improves or if activities that lead to health promotion are started.
The effectiveness level reception unit 213 transmits a combination of the material ID and effectiveness level of the material used, which is the material displayed in step S43, to the medication guidance device 10. The score setting unit 112 receives a set of material ID and effectiveness of the used material.

(Step S52: Effectiveness determination process)
The score setting unit 112 determines whether the effectiveness indicates that the materials used are effective.
If the effectiveness indicates that the point setting unit 112 is effective, the score setting unit 112 advances the process to step S53. On the other hand, when the effectiveness indicates that the effectiveness is not effective, the score setting unit 112 ends the process.

(Step S53: Point setting process)
The score setting unit 112 adds 1 to the effect score set in the record of the condition determined to satisfy the condition in step S32 among the material ID records transmitted by the effectiveness reception unit 213 in the material characteristic information 133. . The conditions determined to be satisfied in step S32 may be retained in the memory 12, or may be specified based on the characteristics of the previous visit to the store.

In addition, in the process of FIG. 12, points were added to the effect score when it was effective. However, instead of adding points to the effect score when it is effective, the effect score may be subtracted when it is not effective. Furthermore, in addition to adding points to the effect score when the effect is effective, the effect score may be subtracted when the effect is not effective.

***Effects of Embodiment 1***
As described above, the medication guidance device 10 according to Embodiment 1 identifies one or more materials having characteristics corresponding to a patient, gives priority to them, and presents them. Thereby, the pharmacist can easily select appropriate materials by referring to the materials with the highest priority.

The medication guidance device 10 according to the first embodiment accepts input of the effectiveness of the materials used, and sets the effectiveness score of the material based on the effectiveness. Then, the medication guidance device 10 gives priority based on the effect score. This makes it possible to give appropriate priority to materials.

***Other configurations***
<Modification 1>
In the first embodiment, the medication guidance device 10 and the pharmacy terminal 20 are provided with functional components distributed. However, the functional components of the medication guidance system 100 only need to be provided in the medication guidance system 100, and either the medication guidance device 10 or the pharmacy terminal 20 may be provided with the functional components.

For example, pharmacy terminal 20 may include all functional components. With this configuration, the medication guidance device 10 can be regarded as a database server for storing data.
Further, for example, the medication guidance device 10 may include all functional components. With this configuration, the pharmacy terminal 20 can be regarded as a terminal that only serves as an interface with the pharmacist.

Further, the medication guidance system 100 may be configured with one computer. In other words, one computer may have the functions of both the medication guidance device 10 and the pharmacy terminal 20.

<Modification 2>
In the first embodiment, the effectiveness indicated whether or not the used materials were effective. However, the effectiveness may be a score indicating the effectiveness of the materials used. Here, it is assumed that the higher the effectiveness, the higher the score. For example, when assigning points in three stages, 3 points are the highest in effectiveness, and 1 point is the lowest.
In this case, the process from step S52 to step S53 in FIG. 12 is changed to a process of adding the score indicated by the effectiveness of the target group to the effect score for the material ID of the target group.

<Modification 3>
Some materials have multiple pages. In this case, the contents differ slightly depending on the page.
In the first embodiment, the material characteristic information 133 includes a set of one or more conditions and an effect score for each pharmacy ID and material ID. As a third modification, as shown in FIG. 13, considering that one material has multiple pages, the material characteristic information 133 includes one or more pages for each pharmacy ID, material ID, and page number. A set of a condition and an effect score may be included. This allows the pharmacist to easily select which page of which material to use.

For example, in the case of "continuous prescription of drug B", both the 1st page and 2nd page of the material with the material ID S001 satisfy the conditions. In this case, in step S3 of FIG. 8, for the material IDS001, the record of page 1 and page 2, which has the highest effect score, is identified. Then, in step S4 of FIG. 8, two pages of material IDS001 are displayed. At this time, priority is assigned using the effect score of the two-page record.
In step S51 of FIG. 12, the effectiveness level reception unit 213 transmits a set of the material ID, page number, and effectiveness level of the materials to be used to the medication guidance device 10. In step S53 of FIG. 12, the score setting unit 112 selects the record of the condition determined to satisfy the condition in step S32 among the records of the material ID and page number transmitted by the effectiveness reception unit 213 in the material characteristic information 133. Add 1 to the effect score set in .

<Modification 4>
In the first embodiment, each functional component is realized by software. However, as a fourth modification, each functional component may be realized by hardware. Regarding this modification 4, differences from the first embodiment will be explained.

When each functional component is realized by hardware, the medication guidance device 10 includes an electronic circuit in place of the processor 11, memory 12, and storage 13. The electronic circuit is a dedicated circuit that realizes each functional component of the medication guidance device 10, the memory 12, and the storage 13.

Similarly, when each functional component is realized by hardware, the pharmacy terminal 20 includes an electronic circuit instead of the processor 21, memory 22, and storage 23. The electronic circuit is a dedicated circuit that realizes each functional component of the pharmacy terminal 20, the memory 22, and the storage 23.

Possible electronic circuits include single circuits, composite circuits, programmed processors, parallel programmed processors, logic ICs, GAs, ASICs, and FPGAs. GA is an abbreviation for Gate Array. ASIC is an abbreviation for Application Specific Integrated Circuit. FPGA is an abbreviation for Field-Programmable Gate Array.
Each functional component may be realized by one electronic circuit, or each functional component may be realized by being distributed among a plurality of electronic circuits.

<Modification 5>
As a fifth modification, some of the functional components may be realized by hardware, and other functional components may be realized by software.

The processor 11, memory 12, storage 13, and electronic circuit are referred to as a processing circuit. That is, the functions of each functional component are realized by the processing circuit.

Embodiment 2.
The second embodiment differs from the first embodiment in that the material ID of the material characteristic information 133 has a subnumber. In the second embodiment, this different point will be explained, and the explanation of the same point will be omitted.

The material characteristic information 133 according to the second embodiment will be explained with reference to FIG. 14.
The material characteristic information 133 differs from the material characteristic information 133 shown in FIG. 6 in that the material ID has a subnumber.
The subnumber is a branch number of the material ID. In the second embodiment, the larger the subnumber, the more sets of characteristics the conditions are set. Therefore, when a plurality of conditions that can be satisfied simultaneously for one material are set, the larger the sub number, the more difficult it becomes to satisfy the conditions. Therefore, the larger the subnumber, the stronger the degree of adaptation with the corresponding patient attribute.
For example, for materials in material IDS001, there are records with sub numbers 1 to 3. In the record with sub-number 1, the condition is that the person is a "diabetic patient." In the record with sub-number 3, the conditions are that the patient is "prescribed drug A for the first time, and is a male diabetic patient." Therefore, if the condition for the record with sub-number 3 is satisfied, the condition for the record with sub-number 1 is also satisfied. The record with sub-number 3, which has a large sub-number, has stricter conditions than the record with sub-number 1, making it difficult to satisfy the conditions.
Note that, like the material IDS010, settings can be made such that only one condition is satisfied.

Referring to FIG. 15, the instruction information transmission process (step S3 in FIG. 8) according to the second embodiment will be described.
Processing other than step S33 and step S34 is the same as in the first embodiment.

(Step S33: Characteristic ID extraction process)
The material identification unit 111 extracts material IDs that satisfy the conditions.
Specifically, the material specifying unit 111 extracts a material ID of a material whose characteristics corresponding to a patient satisfy at least one of the conditions. At this time, the material specifying unit 111 extracts an effect score set for a condition that has a large number of characteristics forming the condition from among the conditions that are satisfied by the characteristics corresponding to the patient. In other words, the material specifying unit 111 extracts the effect score of the record with the largest subnumber among the conditions satisfied by the characteristics corresponding to the patient. Further, the material specifying unit 111 specifies the number of characteristics forming the condition of the record with the largest subnumber.

(Step S34: Information transmission process)
The material identification unit 111 sends the information extracted in step S32 and the combination of the material ID, the effect score, and the number of characteristics constituting the conditions extracted in step S33 to the pharmacy terminal 20 that is the source of the request information. Send.

Referring to FIG. 16, the instruction information display process (step S4 in FIG. 8) according to the second embodiment will be described.
Processing other than step S41 is the same as in the first embodiment.

(Step S41: Information display processing)
As in the first embodiment, the presentation unit 212 displays information about the patient on the display device, and also displays the material ID and the summary corresponding to the material ID in the material information 231.
However, at this time, the presenting unit 212 gives priority based on the number of characteristics and the effect score that constitute the conditions transmitted in step S3. For example, the presenting unit 212 assigns a priority based on a value obtained by multiplying the effect score by the number of characteristics forming the condition.

Referring to FIG. 17, the instruction result registration process (step S5 in FIG. 8) according to the second embodiment will be described.
Processing other than step S53 is the same as in the first embodiment.

(Step S53: Point setting process)
The score setting unit 112 selects a record of a condition that is satisfied by the characteristic corresponding to a patient among records of the material ID of the target set in the material characteristic information 133, and a record of a condition that has a large number of characteristics constituting the condition. Add 1 to the set effect score. That is, the score setting unit 112 adds 1 to the effect score set for the record that is the record of the condition that is satisfied by the characteristics corresponding to the patient and has the largest subnumber.

***Effects of Embodiment 2***
As described above, the medication guidance device 10 according to the second embodiment gives the material ID a subnumber. Then, the medication guidance device 10 assigns a priority based on the effect score set for the condition with the largest number of characteristics constituting the condition among the conditions satisfied by the characteristics corresponding to the patient, and the number of characteristics constituting the condition. Give. This makes it possible to give a priority that is more suited to the patient.

***Other configurations***
<Modification 6>
In the second embodiment, priority is given to each material ID based on the number of characteristics forming the condition and the effect score. However, priority may be given to each material ID based on the total effect score for conditions satisfied by the characteristics corresponding to the patient.
In this case, in step S33 of FIG. 15, the material specifying unit 111 extracts the material ID of the material whose characteristics corresponding to the patient satisfy at least one of the conditions. At this time, the material specifying unit 111 extracts and totals the effect scores set for all conditions satisfied by the characteristics corresponding to the patient for the extracted material ID. In step S34 of FIG. 15, the material identification unit 111 sends the information extracted in step S32 and the set of material ID and total effect score extracted in step S33 to the pharmacy terminal 20 that is the source of the request information. Send. Then, in step S41 of FIG. 6, the presentation unit 212 assigns a priority based on the total number of effect points transmitted in step S3.

<Modification 7>
In the second embodiment, in step S54 of FIG. 17, the score setting unit 112 sets a record of conditions that are satisfied by the characteristics corresponding to the patient and that has a large number of characteristics constituting the conditions. Added points to the effect score. However, the score setting unit 112 may add points to the effect scores of all records of conditions that are satisfied by the characteristics corresponding to the patient. At this time, the score setting unit 112 may increase the number of points added as the number of characteristics forming the condition increases.

Note that "unit" in the above description may be read as "circuit", "step", "procedure", "process", or "processing circuit".

Hereinafter, various aspects of the present disclosure will be collectively described as supplementary notes.
(Additional note 1)
a material identification unit that identifies one or more materials having characteristics corresponding to a patient to whom a drug is prescribed by referring to material characteristic information indicating characteristics of each of a plurality of materials to be presented to a patient during medication guidance;
A medication guidance system comprising: a presentation section that presents each of the one or more materials specified by the material identification section based on priority.
(Additional note 2)
The medication guidance system according to Supplementary Note 1, wherein the characteristics include a drug prescribed to the patient, and at least one of the number of prescriptions and the prescription interval of the prescribed drug.
(Additional note 3)
The medication guidance system according to appendix 1 or 2, wherein the characteristics include a disease of the patient.
(Additional note 4)
The medication guidance system according to appendix 2, wherein the characteristics include at least one of the patient's constitution, allergies, luxury items, and concomitant medications.
(Appendix 5)
The medication guidance system according to appendix 3, wherein the characteristics include at least one of the patient's constitution, allergies, luxury items, and concomitant medications.
(Appendix 6)
The medication guidance system further includes:
an effectiveness reception unit that receives an input of effectiveness when medication guidance is provided using a material that is any one of the plurality of materials;
a score setting unit that sets an effect score to the used material based on the effectiveness received by the effectiveness reception unit;
The medication guidance system according to any one of Supplementary Notes 1 to 5, wherein the presentation unit assigns the priority based on the effect score set by the score setting unit.
(Appendix 7)
In the material characteristic information, one or more conditions constituted by one or more sets of characteristics are defined for one material, and the effect score is set for each condition,
The material identifying unit identifies a material whose characteristics corresponding to the patient satisfy at least one of the one or more conditions,
The medication guidance system according to appendix 6, wherein the presentation unit assigns the priority based on the number of characteristics constituting the conditions and the effect score among the conditions satisfied by the characteristics corresponding to the patient.
(Appendix 8)
In the material characteristic information, one or more conditions constituted by one or more sets of characteristics are defined for one material, and the effect score is set for each condition,
The material identifying unit identifies a material whose characteristics corresponding to the patient satisfy at least one of the one or more conditions,
6. The medication guidance system according to appendix 6, wherein the presentation unit assigns the priority based on a total of effect scores for conditions satisfied by the characteristics corresponding to the patient.
(Appendix 9)
The score setting unit is configured to set the effect score to a condition that has a large number of characteristics forming the condition among conditions that are satisfied by the characteristics corresponding to the patient defined for the material to be used, based on the effectiveness degree. The medication guidance system according to appendix 7 or 8, which adds points only to.
(Appendix 10)
Based on the effectiveness, the score setting unit may set the effectiveness score to a condition that is satisfied by the characteristics corresponding to the patient defined for the material used, as the number of characteristics forming the condition increases. The medication guidance system according to appendix 7 or 8, which adds a large number of points.
(Appendix 11)
The presentation unit accepts the selection of the material, determines that medication guidance has been provided using the selected material, and stores information about the selected material as a medication guidance history according to any one of Supplementary Notes 1 to 10. Medication guidance system described.
(Appendix 12)
the computer refers to material characteristic information indicating the characteristics of each of the plurality of materials to be presented to the patient during medication guidance, and identifies one or more materials having characteristics corresponding to the patient to whom the drug is prescribed;
A medication guidance method in which a computer presents each of the one or more materials based on priority.
(Appendix 13)
a material identification process that identifies one or more materials having characteristics corresponding to a patient to whom a drug is prescribed by referring to material characteristic information indicating the characteristics of each of a plurality of materials to be presented to a patient during medication guidance;
A medication guidance program that causes a computer to function as a medication guidance system that performs a presentation process of presenting each of the one or more materials specified by the material identification process based on priority.

The embodiments and modifications of the present disclosure have been described above. Some of these embodiments and modifications may be implemented in combination. Moreover, any one or some of them may be partially implemented. Note that the present disclosure is not limited to the above embodiments and modifications, and various changes can be made as necessary.

100 Medication Guidance System, 10 Medication Guidance Device, 11 Processor, 12 Memory, 13 Storage, 14 Communication Interface, 111 Material Identification Unit, 112 Point Setting Unit, 131 Patient Information, 132 Prescription Information, 133 Material Characteristic Information, 20 Pharmacy Terminal, 21 processor, 22 memory, 23 storage, 24 communication interface, 211 prescription processing unit, 212 presentation unit, 213 validity reception unit, 231 material information, 90 network.

Claims (12)

When giving medication guidance, one or more conditions constituted by one or more sets of characteristics are determined for each of multiple materials presented to the patient, and material characteristic information is referenced in which an effect score is set for each condition. a material identification unit that identifies a material ID of one or more materials whose characteristics corresponding to a patient to whom the drug is prescribed satisfies at least one of the one or more conditions ;
a presentation unit that presents each material indicated by one or more material IDs specified by the material identification unit based on the priority of the material ;
an effectiveness reception unit that receives an input of effectiveness when medication guidance is provided using a material that is any one of the plurality of materials;
a score setting unit that sets the effect points for each of the conditions for the used materials based on the effectiveness received by the effectiveness reception unit;
Equipped with
The presentation unit determines the priority for each of the one or more materials based on the effect score set for a condition satisfied by the characteristics corresponding to the patient for each of the one or more materials. A medication guidance system that provides 2. The medication guidance system according to claim 1, wherein the characteristics include at least one of the medicine prescribed to the patient, the number of times the prescribed medicine is prescribed, and the prescription interval. The medication guidance system according to claim 1, wherein the characteristics include a disease of the patient. 3. The medication guidance system according to claim 2, wherein the characteristics include at least one of the patient's constitution, allergies, luxury items, and concomitant medications. 4. The medication guidance system according to claim 3, wherein the characteristics include at least one of the patient's constitution, allergies, luxury items, and concomitant medications. The medication guidance system according to claim 1 , wherein the presentation unit assigns the priority based on the number of characteristics constituting a condition and an effect score among conditions satisfied by characteristics corresponding to the patient. 2. The medication guidance system according to claim 1 , wherein the presentation unit assigns the priority based on a total of effect scores for conditions satisfied by characteristics corresponding to the patient. The score setting unit is configured to set the effect score to a condition that has a large number of characteristics forming the condition among conditions that are satisfied by the characteristics corresponding to the patient defined for the material to be used, based on the effectiveness degree. 7. The medication guidance system according to claim 6 , which adds points only to. Based on the effectiveness, the score setting unit may set the effectiveness score to a condition that is satisfied by the characteristics corresponding to the patient defined for the material used, as the number of characteristics forming the condition increases. 7. The medication guidance system according to claim 6 , wherein a large number of points are added. The medication guidance system according to claim 1, wherein the presentation unit receives the selection of the material, determines that medication guidance has been performed using the selected material, and stores information about the selected material as a medication guidance history. Material characteristic information in which one or more conditions constituted by one or more sets of characteristics are determined for each of a plurality of materials that a computer presents to a patient during medication guidance, and an effect score is set for each condition. with reference to, identify the material ID of one or more materials whose characteristics corresponding to the patient to whom the drug is prescribed satisfy at least one of the one or more conditions ;
The computer presents each material indicated by the identified one or more material IDs based on the priority of the material ,
The computer receives an input of the degree of effectiveness when giving medication guidance using a material used that is any one of the plurality of materials,
a computer sets the effectiveness points for each of the conditions for the used materials based on the accepted effectiveness;
The computer assigns the priority to each of the one or more materials based on the effect score set for the condition satisfied by the characteristic corresponding to the patient for the target material. Medication guidance method. When giving medication guidance, one or more conditions constituted by one or more sets of characteristics are determined for each of multiple materials presented to the patient, and material characteristic information is referenced in which an effect score is set for each condition. a material identification process for identifying a material ID of one or more materials whose characteristics corresponding to a patient to whom the drug is prescribed satisfy at least one of the one or more conditions ;
a presentation process that presents each material indicated by one or more material IDs identified by the material identification process based on the priority of the material ;
an effectiveness level reception process that receives an input of effectiveness level when medication guidance is provided using a material used that is any one of the plurality of materials;
a score setting process of setting the effect points for each of the conditions for the used materials based on the effectiveness received by the effectiveness acceptance process;
The computer functions as a medication guidance system for
In the presentation process, for each of the one or more materials, the priority is determined for the target material based on the effect score set for the condition that the characteristic corresponding to the patient satisfies for the target material. Medication guidance program that provides

Images